Gynecologic and Reproductive Health Concerns of Adolescents Using Selected Psychotropic Medications

2009, Practice parameter on the use of psychotropic medication in children and adolescents, J Am Acad Child Adolesc Psychiatry, 48, 961, 10.1097/CHI.0b013e3181ae0a08 Correll, 2011, Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics, J Clin Psychiatry, 72, 655, 10.4088/JCP.11r07064 Zito, 2003, Psychotropic practice patterns for youth: a 10-year perspective, Arch Pediatr Adolesc Med, 157, 17, 10.1001/archpedi.157.1.17 Wong, 2004, Increased prescribing trends of paediatric psychotropic medications, Arch Dis Child, 89, 1131, 10.1136/adc.2004.050468 Panagiotopoulos, 2010, First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents, Can Acad Child Adolesc Psychiatry, 19, 124 Correll, 2006, Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents, J Am Acad Child Adolesc Psychiatry, 45, 771, 10.1097/01.chi.0000220851.94392.30 Correll, 2008, Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes, J Am Acad Child Adolesc Psychiatry, 47, 9, 10.1097/chi.0b013e31815b5cb1 Correll, 2009, Cardiometabolic risk of second generation antipsychotic medications during first time use in children and adolescents, JAMA, 302, 1765, 10.1001/jama.2009.1549 Correll, 2010, Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo controlled trials, Bipolar Disord, 12, 116, 10.1111/j.1399-5618.2010.00798.x Pringsheim, 2011, Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials, Drug Saf, 34, 651, 10.2165/11592020-000000000-00000 De Hert, 2011, Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice, Eur Psychiatry, 26, 144, 10.1016/j.eurpsy.2010.09.011 Joffe, 2008, Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents, Ann N Y Acad Sci, 1135, 219, 10.1196/annals.1429.030 Brown, 2010, Psychiatric disorders and sexual risk among adolescents in mental health treatment, J Consult Clin Psychol, 78, 590, 10.1037/a0019632 Olfson, 2006, National trends in the outpatient treatment of children and adolescents with antipsychotic drugs, Arch Gen Psychiatry, 63, 679, 10.1001/archpsyc.63.6.679 Mancini, 2008, Hyperprolactinemia and prolactinomas, Endocrinol Metab Clin N Am, 37, 67, 10.1016/j.ecl.2007.10.013 Molitch, 2005, Medication-induced hyperprolactinemia, Mayo Clinic Proc, 80, 1050, 10.4065/80.8.1050 Correll, 2011, Antipsychotic agents: traditional and atypical, 313 Findling, 2009, Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study, J Clin Psychiatry, 70, 1441, 10.4088/JCP.09m05164yel Findling, 2008, A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia, Am J Psychiatr, 165, 1432, 10.1176/appi.ajp.2008.07061035 Roke, 2009, Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects, J Child Adolesc Psychopharmacol, 19, 403, 10.1089/cap.2008.0120 Haddad, 2004, Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management, Drugs, 64, 2291, 10.2165/00003495-200464200-00003 Anderson, 2007, Effects of short- and long-term risperidone treatment on prolactin levels in children with autism, Biological Psychiatry, 61, 545, 10.1016/j.biopsych.2006.02.032 Saito, 2004, A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents, J Child Adolesc Psychopharmacol, 14, 350, 10.1089/cap.2004.14.350 Woods, 2002, Effects of development on olanzapine-associated adverse events, J Am Acad Child Adolesc Psychiatry, 41, 1439, 10.1097/00004583-200212000-00015 Seeman, 1987, Human brain dopamine receptors in children and aging adults, Synapse, 1, 399, 10.1002/syn.890010503 Becker, 2006, Female puberty: clinical implications for the use of prolactin modulating psychotropics, Child Adolesc Psychiatr Clin N Am, 15, 207, 10.1016/j.chc.2005.08.006 Anderson, 2007, Effects of short and long-term risperidone treatment on prolactin levels in children with autism, Biol Psychiatry, 61, 545, 10.1016/j.biopsych.2006.02.032 Dunbar, 2004, Growth and sexual maturation during long-term treatment with risperidone, Am J Psychiatry, 161, 918, 10.1176/appi.ajp.161.5.918 Becker, 2003, Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients, J Clin Psychiatry, 64, 761, 10.4088/JCP.v64n0704 Calarge, 2010, A cross-sectional evaluation of the effect of risperidone and selective seratonin reuptake inhibitors on bone mineral density in boys, J Clin Psychiatry, 71, 338, 10.4088/JCP.08m04595gre Ho, 2011, Management recommendations for metabolic complications associated with second generation antipsychotic use in children and youth, J Can Acad Child Adolesc Psychiatry, 20, 234 Calarge, 2009, Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents, Pharmacogenet Genomics, 19, 373, 10.1097/FPC.0b013e328329a60f Alfaro, 2002, Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine, J Child Adolesc Psychopharmacol, 12, 83, 10.1089/104454602760219126 Lian, 2010, Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole, Prog Neuropsychopharmacol Biol Psychiatry, 34, 1157, 10.1016/j.pnpbp.2010.03.035 Cohen, 2001, Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children, J Child Adolesc Psychopharmacol, 11, 435, 10.1089/104454601317261618 Szarfman, 2006, Atypical antipsychotics and pituitary tumors: a phmacoviginlance study, Pharmacotherapy, 26, 748, 10.1592/phco.26.6.748 Kelly, 2004, Atypical antipsychotic use in a state hospital inpatient adolescent population, J Child and Adolesc Psychopharmacol, 14, 75, 10.1089/104454604773840517 Jerrell, 2009, Hyperprolactinemia-related adverse events associated with antipsychotic treatment in children and adolescents, J Adolesc Health, 45, 70, 10.1016/j.jadohealth.2008.11.010 Greenspan, 2005, Thyroid dysfunction during treatment with atypical antipsychotics, J Clin Psychiatry, 66, 1334, 10.4088/JCP.v66n1019e Kakuno, 2010, Menstrual disturbances in various thyroid diseases, Endocr J, 57, 1017, 10.1507/endocrj.K10E-216 Talib, 2012, Excessive Uterine Bleeding, Adolesc Med, 23, 53 Kelly, 2005, Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone or fluphenazine, J Clin Psychiatry, 66, 80, 10.4088/JCP.v66n0111 Lombardi, 1993, Effects of lithium treatment on hypothalamic-pituitary-thyroid axis, J Endocrinol Invest, 16, 2590, 10.1007/BF03348825 Lazarus, 2009, Lithium and thyroid, Best Pract Clin Endocrinol Metab, 23, 723, 10.1016/j.beem.2009.06.002 Gracious, 2004, Elevated thyrotropin in bipolar youths prescribed both lithium and divalproex sodium, J Am Acad Child Adolesc Psychiatry, 43, 215, 10.1097/00004583-200402000-00018 Kafantaris, 2003, Lithium treatment of acute mania in adolescents: a large open trial, J Am Acad Child Adolesc Psychiatry, 42, 1038, 10.1097/01.CHI.0000070247.24125.24 Eirís-Puñal, 1999, Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism, Epilepsia, 40, 1761, 10.1111/j.1528-1157.1999.tb01595.x Vainionpaa, 1999, Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy, Ann Neurol, 45, 444, 10.1002/1531-8249(199904)45:4<444::AID-ANA5>3.0.CO;2-6 Bou Khalil, 2011, Thyroid adverse effects of psychotropic drugs: a review, Clin Neuropharmacol, 36, 248, 10.1097/WNF.0b013e31823429a7 Kowatch, 2011, Mood stabilizers: lithium, anticonvulsants, and others, 297 Moreno, 2007, National trends in the outpatient diagnosis and treatment of bipolar disorder in youth, Arch Gen Psychiatry, 64, 1032, 10.1001/archpsyc.64.9.1032 Isojarvi, 1993, Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy, N Engl J Med, 249, 835 Azziz, 2009, The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, Fertil Steril, 91, 456, 10.1016/j.fertnstert.2008.06.035 Morrell, 2008, Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine, Ann Neurol, 64, 200, 10.1002/ana.21411 Joffe, 2006, Valproate is associated with new-onset oligomenorrhea with hyperandrogenism in women with bipolar disorder, Biol Psychiatry, 59, 1078, 10.1016/j.biopsych.2005.10.017 Bauer, 2000, Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women, Epilepsy Res, 41, 163, 10.1016/S0920-1211(00)00139-X Luef, 2002, Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate, Epilepsy Res, 48, 91, 10.1016/S0920-1211(01)00317-5 Murialdo, 1997, Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy, J Endocrinol Invest, 20, 519, 10.1007/BF03348013 Hu, 2011, A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy, Epilepsy Res, 97, 73, 10.1016/j.eplepsyres.2011.07.006 Nelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarian theca cells, Endrocrinology, 145, 799, 10.1210/en.2003-0940 Herzog, 1996, Temporolimbic epilepsy and polycystic ovary syndrome, Fertil Steril, 43, 341 Joffe, 2006, Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls, J Clin Psychiatry, 67, 297, 10.4088/JCP.v67n0218 Rasgon, 2005, Reproductive function and risk for PCOS in women treated for bipolar disorder, Bipolar Disord, 7, 246, 10.1111/j.1399-5618.2005.00201.x Mikkonen, 2004, Long-term reproductive endocrine health in young women with epilepsy during puberty, Neurology, 62, 445, 10.1212/01.WNL.0000106942.35533.62 2008, ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces Practice Bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation, Obstet Gynecol, 111, 1001 Miller, 1996, Sexuality, pregnancy, and child- bearing among women with schizophrenia-spectrum disorders, Hosp Community Psychiatry, 47, 502 2008, Update on overall prevalence of major birth defects, MMWR Weekly, 57, 1 Epperson, 2011, Psychopharmacology during pregnancy: infant considerations, 313 Ernst, 2002, The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics, J Clin Psychiatry, 63, 42 Walker, 2009, The management of epilepsy in pregnancy, BJOG, 116, 758, 10.1111/j.1471-0528.2009.02141.x Galbally, 2010, Mood stabilizers in pregnancy: a systematic review, Aust N Z J Psychiatry, 44, 967, 10.3109/00048670903487217 Altshuler, 1996, Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines, Am J Psychiatry, 153, 592, 10.1176/ajp.153.5.592 Meador, 2009, Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs, N Engl J Med, 360, 1597, 10.1056/NEJMoa0803531 Eriksson, 2005, Children exposed to valproate in utero: population based evaluation of risks and confounding factors for long-term neurocognitive development, Epilepsy Res, 65, 189, 10.1016/j.eplepsyres.2005.06.001 Gentile, 2011, Drug treatment for mood disorders in pregnancy, Curr Opin Psychiatry, 24, 34, 10.1097/YCO.0b013e3283413451 McCauley-Elsom, 2010, Antipsychotics in pregnancy, J Psychiatr Ment Health Nurs, 17, 97, 10.1111/j.1365-2850.2009.01481.x Gentile, 2010, Antipsychotic therapy during early and late pregnancy. A systematic review, Schizophr Bull, 36, 518, 10.1093/schbul/sbn107 McKenna, 2005, Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study, J Clin Psychiatry, 66, 444, 10.4088/JCP.v66n0406 Schwarz, 2005, Prescription of teratogenic medications in United States ambulatory practices, Am J Med, 118, 1240, 10.1016/j.amjmed.2005.02.029 Schwarz, 2007, Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women, Ann Intern Med, 147, 370, 10.7326/0003-4819-147-6-200709180-00006 Steinkellner, 2010, Adherence to oral contraception in women on Category X medications, Am J Med, 123, 929, 10.1016/j.amjmed.2010.05.009 Long, 2005, Knowledge of women’s health issues and epilepsy (KOWIE-II): a survey of health care professionals, Epilesy Behav, 6, 90, 10.1016/j.yebeh.2004.11.006 McIntyre, 2009, Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study, J Clin Psychiatry, 70, 240, 10.4088/JCP.08m04212 Oesterheld, 2011, Cytochrome P450-mediated drug interactions, 50 Bacopoulou, 2010, Reproductive and contraceptive issues in chronically ill adolescents, Eur J Contracept Reprod Health Care, 15, 389, 10.3109/13625187.2010.532252 2010, U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th edition, MMWR Recomm Rep, 59, 1 Gaffield, 2011, The use of hormonal contraception among women taking anticonvulsant therapy, Contraception, 83, 16, 10.1016/j.contraception.2010.06.013 Haslemo, 2011, The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine, Br J Clin Pharmacol, 71, 611, 10.1111/j.1365-2125.2010.03880.x Gabbay, 2002, Colazpine and oral contraceptives: a possible drug interaction, J Clin Psychopharmacol, 22, 621, 10.1097/00004714-200212000-00013 Herzog, 2009, Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use, Neurology, 72, 911, 10.1212/01.wnl.0000344167.78102.f0 Christensen, 2007, Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial, Epilepsia, 48, 484, 10.1111/j.1528-1167.2007.00997.x Pack, 2009, Antiepileptic drugs: are women are of interactions with oral contraceptives and potential teratogenicity?, Epilepsy Behav, 14, 640, 10.1016/j.yebeh.2009.01.024